Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
CRO (3)
199 Articles Available
3
9
Can't find what you're looking for? Try our
advanced search
.
Novel Medicine
WuXi Laboratory Testing Division: Propelling Innovation and Better Treatments for Patients
PAO-M05-18-CL-004
Strategic Partnership
Charles River Laboratories to Expand Partnership with PathoQuest
PAO-M04-18-NI-011
Acquisition
Citoxlab Acquires Solvo Biotechnology
PAO-M03-18-NI-025
CRO
Diurnal Selects Worldwide Clinical Trials as Preferred CRO Provider
PR-M03-18-NI-050
Discovery
A New Landscape: M&A in the Discovery & Research Sector
PAP-Q1-18-NI-002
Oncology
Charles River Laboratories Announces New Online Tool
PAO-M03-18-NI-003
Appointment
Charles River Laboratories Announces Executive Management Appointments
PR-M02-18-NI-58
Acquistion
Charles River Laboratories to Acquire MPI Research
PR-M02-18-NI-57
Clinical Trials
Rexgenero Treats First Patient in its Phase III Programme with Lead Product REX-001, a Novel Cell Therapy for the Treatment of Critical Limb Ischemia (CLI)
PR-M01-18-NI-093
Contract Research Organization Growth and Investment
APR-M10-17-NI-001
Acquistion
Charles River Laboratories Acquires KWS BioTest
PR-M01-18-NI-040
Immunology
Charles River Laboratories Gains Immunology Contract Research Services
PAO-M01-18-NI-023
Clinical Trials
BerGenBio Meets First Efficacy Endpoint in Phase II Trial With Selective AXL Inhibitor BGB324 (bemcentinib) in NSCLC
PR-M01-18-NI-035
Bioequivalence Study
Biohaven Announces Positive Results From Bioequivalence Study With Sublingual BHV-0223 Zydis® Orally Dissolving Tablet
PR-M01-18-NI-034
Joint Venture
WuXi AppTec Group and Mayo Clinic Form Joint Venture to Deliver Clinical Diagnostic Services
PR-M01-18-NI-027
Hires
AMRI Names Michael Mulhern as Chief Executive Officer
PR-M01-18-NI-012
Business
PPD Names Colin Hill, CEO of GNS Healthcare, to its Board of Directors
PR-M01-18-NI-007
FDA Guidance
FDA Received Numerous Comments on Its Draft Guidance for Evaluating Biosimilarity
PAO-M01-18-NI-004
Research
Tumor Killing Combo Wins Third U.S. Patent
PAO-M12-17-NI-033
Mergers & Acquistions
Five Critical Considerations for Pharmaceutical M&A
PAO-M12-17-Cl-001
Drug Development
Thermo Fisher Scientific’s Patheon Division to Manufacture Nasal Formulation for Evoke Pharma
PAO-M12-17-NI-003
Strategic Partnership
New Collaboration Targets the Development of Oligonucleotides
PAO-M12-17-NI-002
Clinical Research
CRO Pharmaceutical Product Development Wins NIH Contract for HIV Research
PAO-M11-17-NI-021
CRO
CitoxLab acquires Xenometrics, an American CRO specialized in preclinical assessment of new drug candidates
PR-M10-17-NI-010
«
3
9
»
.svg)
